InvestorsHub Logo

Bored Lawyer

10/18/17 4:25 PM

#12509 RE: ninersax #12508

Agree to disagree, but I appreciate the civil response.

I'm here because Prolanta received ODD designation and the initial science behind appears promising.

To demonstrate that science, the company has to run a Phase I trial (and then Phase II, Phase III, etc. if things go right), and that costs money.

If the science works, then debt, etc. will affect overall return but we will all make money (with when and how much TBD) buying at these levels.

Time will tell if I'm right.

Either way, GLTA!

dabullishbear

10/18/17 4:49 PM

#12511 RE: ninersax #12508

The debt is relatively normal for a research and development bio company. I don't believe that will scare anyone off. Didn't scare off the venture capitalists who are 100 times more savvy and knowledgeable than any of us here. These guys have put in $15m+ into Oncolix. Why on earth would they do that if they didn't believe in this company?

Give me a good reason why they would invest so much if the company is garbage.